The Weekly Litigation News Digest is now live. Subscribe now

Universit Laval competitive analysis

Loading summary...

Explore Universit Laval's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Sep 19, 2018Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging1

Latest PTAB cases involving Universit Laval

Discover the latest PTAB cases involving Universit Laval, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Universit Laval with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSIT LAVAL - 1 - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - -